Hints and tips:
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...their way out of the laboratory into run-of-the-mill reality....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Last year, it splashed out $8.8bn for Millennium Pharmaceuticals, a Bostonian biotech with a cancer drug on sale....
...A few months later Daiichi Sankyo, the third-largest Japanese drugsmaker, bought Ranbaxy Laboratories, India’s biggest generic drugsmaker, in a cash deal worth up to $4.6bn....
...Millennium IT has developed, in laboratory conditions at a facility in the UK, what it claims is the fastest trading system in the world....
...Takeda, Japan’s largest drug company, said in April it would buy US drug company Millennium Pharmaceuticals for $8.5bn. Some of those consolidation efforts have borne bitter fruit, however....
...In April, Takeda, the country’s largest pharmaceutical group, agreed to pay $8.5bn to take over Millennium Pharmaceuticals of the US, after buying full control of TAP, its US joint venture with Abbott established...
...Takeda Parmaceutical has said it will pay $8.8bn to take over Millennium, a US biotechnology company, while Daiichi Sankyo offered $4.6bn for Ranbaxy Laboratories, India’s biggest generic drugs maker....
...Daiichi Sankyo, Japan’s third-largest pharmaceutical company, is to take control of Ranbaxy Laboratories, India’s biggest generic drugs maker, in a cash deal worth up to $4.6bn....
...It jumped from 17th to 14th largest drug company in the world in March when it paid about $1.5bn for the bigger half of TAP, its longstanding joint venture with Abbott Laboratories of the US....
...Earlier this month Takeda Pharmaceutical agreed to buy Boston-based Millennium Pharmaceuticals for $8.8bn in the biggest foreign acquisition by a Japanese pharmaceutical group....
...His rival, G.V....
International Edition